Evidence map›Paper›PMID 39457303›Full record

ArticleInternational journal of environmental research and public health2024

Stakeholder Perspectives on the Acceptability, Design, and Integration of Produce Prescriptions for People with Type 2 Diabetes in Australia: A Formative Study.

Kristy K Law, Kathy Trieu, Jennifer Madz, Daisy H Coyle, Kimberly Glover, Maoyi Tian, Yuze Xin, David Simmons, Jencia Wong, Jason H Y Wu

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kristy K LawThe George Institute for Global Health, University of New South Wales, Sydney, NSW 2000, Australia.ORCID 0000-0002-0542-0114
Kathy TrieuThe George Institute for Global Health, University of New South Wales, Sydney, NSW 2000, Australia.ORCID 0000-0003-1848-2741
Jennifer MadzDiabetes Australia, Sydney, NSW 2037, Australia.
Daisy H CoyleThe George Institute for Global Health, University of New South Wales, Sydney, NSW 2000, Australia.
Kimberly GloverThe George Institute for Global Health, University of New South Wales, Sydney, NSW 2000, Australia.ORCID 0000-0003-3019-1912
Maoyi TianThe George Institute for Global Health, University of New South Wales, Sydney, NSW 2000, Australia.ORCID 0000-0002-5660-8571
Yuze XinSchool of Public Health, Harbin Medical University, Harbin 150081, China.ORCID 0009-0003-6955-6154
David SimmonsSchool of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia.ORCID 0000-0003-0560-0761
Jencia WongDiabetes Centre, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.
Jason H Y WuThe George Institute for Global Health, University of New South Wales, Sydney, NSW 2000, Australia.ORCID 0000-0003-2073-3562

Funding

Future Food Systems Cooperative Research Centre P3-004Ian Potter Foundation 31111262
6 · The paper itself

Abstract

Produce prescription programs can benefit both individuals and health systems; however, best practices for integrating such programs into the Australian health system are yet unknown. This study explored stakeholders' perspectives on the acceptability, potential design and integration of produce prescription programs for adults with type 2 diabetes in Australia. Purposive sampling was used to recruit 22 participants for an online workshop, representing six stakeholder groups (government, healthcare service, clinician, food retailer, consumer, non-government organisation). Participant responses were gathered through workshop discussions and a virtual collaboration tool (Mural). The workshop was video-recorded and transcribed verbatim, and thematic analysis was conducted using a deductive-inductive approach. Stakeholders recognised produce prescription as an acceptable intervention; however, they identified challenges to implementation related to contextuality, accessibility, and sustainability. Stakeholders were vocal about the approach (e.g., community-led) and infrastructure (e.g., screening tools) needed to support program design and implementation but expressed diverse views about potential funding models, indicating a need for further investigation. Aligning evaluation outcomes with existing measures in local, State and Federal initiatives was recommended, and entry points for integration were identified within and outside of the Australian health sector. Our findings provide clear considerations for future produce prescription interventions for people with type 2 diabetes.

Indexed as

Diabetes Mellitus, Type 2AdultAustraliaFemaleHumansMaleMiddle AgedPrescriptionsStakeholder Participationfood insecurityFood is Medicinehealthcarenutritionqualitative researchsocial prescriptiontype 2 diabetes

Identifiers

PMID39457303
PMCPMC11507040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.